Page 0005



Welcome to Cancer Control 2021

Our interview with Dr Andre Ilbawi does much to

widen our horizons by considering the patient

experience and how, perhaps, the clinical "War on

Cancer" should be tempered by the other levers that are

required to move forward. Not least those coming from the

patient experience which may seem disconnected from such a

bellicose approach. Smita Srinivas, from the Open University

in the United Kingdom, also raises doubts the rhetoric of

the "War on Cancer" and suggest that we should look at the

economic concepts that drive healthcare and bring in some

new perspectives.

A good illustration of how networks can be used is provided

by the SIOP Global Mapping Programme for paediatric cancer

in Africa. In this article, we break format as individual members

of the programme focus on the areas that they had charge of

which range from limited access to cancer care, establishing

cancer societies, national cancer registries and many more.

Here, we see the power of a network bringing results.

But where do networks come from? Another of our articles

looks at the experiences of three different cancer network: the

UK Global Cancer Network, which is mapping links between

UK professionals and LMICs; the Canadian Global Cancer

Network and the City Cancer Challenge, launched by the

UICC in 2017. Their experiences, will be helpful and inspiring

for those seeking to establish the cancer networks they argue

are so necessary.

Keeping an eye on emerging problems is also important

when all eyes are focuse on one crisis. The UICC issue a timely reminder that we must take notice of growing antimicrobial

resistance which poses a complex array of problems for those

treating, and suffering, from cancer. Something we have been

following in depth in our sister publication AMR Control (http:// We, also, have a report from Dr Ibtihal

Fadhil on the Eastern Mediterranean Region, which has been

hit by many geo-political problems beside COVID-19, which

are not fully appreciated. Cancer Control will be publishing

a special report on the region by the same author which will

amplify what is discussed.

Finally, we should not forget research in these times and

therefore we have re-established our R&D chapter with two

articles: one looking at the developing VENUSCANCER study

on disparities in women's globally and another from the Dr

Badel in the Caribbean looking at the racial content of cell lines

and how it needs to be improved to achieve better outcomes. n

We would be delighted to have your feedback at cancercontrol@ Please visit our website www. for updates and also to find out more information

about INCTR and its programmes, as well as how to join.

Dr Ian Magrath, Editor-in-Chief, Cancer Control and President,

International Network for Cancer Treatment and Research.

Tim Probart, MA, Publisher, Cancer Control and CEO, Global

Health Dynamics.

The COVID-19 pandemic is far from over, but healthcare professionals and policymakers are starting to look

towards the way forward for cancer care, which has suffered as healthcare resources have been diverted to

communicable diseases. In this edition look at the wider issues facing global health perspectives at this time:

a more holistic approach to global cancer care; the need for networks that pool all the resources available

(think of COVID-19) to improve cancer care in LMICs; to look at the emerging threats that cancer control

faces; and finally, not to neglect R&D.


  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066